Here's why the Nearmap share price has soared 7% today

The Nearmap Limited (ASX: NEA) share price has soared more than 7% in today's trading session.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nearmap Ltd (ASX: NEA) share price has soared more than 7% in today's trading session. At the time of writing, shares in Nearmap are trading for $2.82.

Why is the Nearmap share price flying?

The company has not released any announcement today that could serve as a catalyst for its share price action. Last week Nearmap announced a US$3.5 million asset acquisition of technology and intellectual property from Primitive LLC (Pushpin). Management are optimistic regarding the combination of Nearmap's 3D imaging and geometry extraction technology acquired from Pushpin.

Equity analysts from Morgan Stanley are also optimistic regarding Nearmap, retaining their overweight rating on the company with a $4.20 price target. According to analysts from the investment bank, the integration of newly acquired technology could generate stronger medium-term growth and revenue.

Nearmap also has a heavy short interest, with 11.1% of its share registry held in short positions. The surge in Nearmap's share price could reflect short sellers covering their position given the positive outlook for the company. The Nearmap share price raced to an all-time-high of $4.23 back in June and has been sold-off since.

What does Nearmap do?

Nearmap is an aerial imagery company that has operations in Australia, New Zealand and the US. Regarded by analysts as best in its class, Nearmap provides digital images from sophisticated cameras mounted on light aircraft. Images are taken from different angles and combined to create high-resolution landscapes, which are stored in an online library. Nearmap serves as a powerful project management tool and reduces the time required for site inspections and planning.

Strong half-year earnings

Earlier this year Nearmap reported impressive half-year earnings, which indicated healthy growth across the board. Highlights of the report included a 46% increase in revenue of $36.3 million and healthy earnings before interest, tax, depreciation and amortisation of $8.1 million. Despite Nearmap reporting a net loss of $1.97 million, down 70% from the year prior, the business is relatively debt free with positive operating cash flow. 

Nearmap considers annualised contract value (ACV) a key metric for customer retention and growth. ACV for the half year grew 44% to $78.3 million indicating strong future revenues, increasing its operating leverage and the prospect of scalability. ACV in the US more than doubled from the previous year to $24.6 million, whilst Australian ACV grew to $53.3 million.

Global growth and expansion

Nearmap's improved performance in the US provided the market with great optimism over the company's future growth and profitability prospects. Nearmap plans to continue expanding its US presence in the near future by expanding operations into more jurisdictions and focusing heavily on sales and marketing to gain market awareness. The company estimates that it has only penetrated 1% of the US market, which it forecasts to be worth approximately $2 billion by 2025.

More competition for Nearmap

Nearmap is also facing local competition after Morgans launched an IPO for aerial imagery and mapping business Aerometrex Ltd (ASX: AMX). Aerometrex is pitched as a mini version of Nearmap and listed on the ASX last week. Following an issue price of $1.00, the Aerometrex share price has surged and currently trading at $1.92.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

man with dog on his lap looking at his phone in his home.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »